(Q33220213)

24 July 2017

Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components (English)

1 reference

24 July 2017

1 reference

Mendelson I

1

1 reference

24 July 2017

Gat O

2

1 reference

24 July 2017

Aloni-Grinstein R

3

1 reference

24 July 2017

Altboum Z

4

1 reference

24 July 2017

Inbar I

5

1 reference

24 July 2017

Kronman C

6

1 reference

24 July 2017

Bar-Haim E

7

1 reference

24 July 2017

Cohen S

8

1 reference

24 July 2017

Velan B

9

1 reference

24 July 2017

Shafferman A

10

1 reference

24 July 2017

language of work or name

English

0 references

publication date

5 February 2005

1 reference

24 July 2017

1 reference

24 July 2017

23

1 reference

24 July 2017

48-49

1 reference

24 July 2017

5688-5697

1 reference

The roles of anthrax toxin in pathogenesis

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

The development of new vaccines against Bacillus anthracis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Development of novel vaccines against anthrax in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid dependent Salmonella typhimurium SL 3261.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

The expression of the protective antigen of Bacillus anthracis in Bacillus subtilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Anthrax vaccines: past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Construction of Bacillus anthracis mutant strains producing a single toxin component.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

A dually active anthrax vaccine that confers protection against both bacilli and toxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Identification of residues lining the anthrax protective antigen channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of Anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Search for correlates of protective immunity conferred by anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

7 January 2021

Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

7 January 2021

Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

7 January 2021

Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

7 January 2021

Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.077

7 January 2021

10.1016/J.VACCINE.2004.11.077

Identifiers

DOI

1 reference

24 July 2017

1 reference